ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:April 21, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:April 21, 2017Completed
Condition(s):B-cell Adult Acute Lymphoblastic Leukemia; Stem Cell Leukemia; Minimal Residual DiseaseLast Updated:February 21, 2022Terminated
Condition(s):Acute Myeloid LeukemiaLast Updated:March 25, 2024Recruiting
Condition(s):Severe Aplastic AnemiaLast Updated:March 18, 2024Recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:April 13, 2023Recruiting
Condition(s):Precursor B-Lymphoblastic Lymphoma/Leukaemia RefractoryLast Updated:October 25, 2017Unknown status
Condition(s):Leukemia; Hodgkin Lymphoma; Lymphoma, Non-Hodgkin’sLast Updated:March 8, 2017Terminated
Condition(s):Myelodysplastic SyndromesLast Updated:March 28, 2024Not yet recruiting
Condition(s):Leukemia, Lymphocytic, AcuteLast Updated:September 6, 2007Unknown status
Condition(s):Leukemia; Lymphoma; Myelodysplastic Syndromes; GvHD; Opportunistic Infections; Graft-versus-Host DiseaseLast Updated:March 16, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.